🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas

Recruitingn/aAges 18 Years - anyAllErasmus Medical Center
NCT06180434 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Rationale: Proton beam therapy has recently become available for the treatment of patients with WHO grade 2 and 3 IDH mutated (IDHmt) glioma in the Netherlands. The dose distributions associated with proton therapy have substantially reduced the volume of the normal brain irradiated with low and intermediate radiotherapy doses. Whether this impacts rates of progressive disease or safety issues and how this compares with a similar population treated with photon therapy is currently unknown. Objective: To investigate short term outcomes after proton and photon radiotherapy for grade 2 and 3 IDHmt glioma.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Histopathologically confirmed WHO grade 2 or grade WHO 3 IDHmt glioma * Treatment with radiotherapy delivered between 1 of January 2018 and completed before or on the 30th of June 2022 * Treatment with chemotherapy delivered after radiotherapy (PCV or Temozolomide) * Age ≥ 18 years Exclusion Criteria: * Prior cranial radiotherapy * Contra-indication for MRI imaging * Chemotherapy delivered before radiotherapy * Dose and fractionation other that standard dose (50.4 Gy in 28 fractions for Grade 2 and 59.5 Gy in 33 fractions for Grade 3) * Combination photon and proton therapy * Patient has previously opted-out of the use of their data for research
💊

What it tests

  • proton therapy
  • photon therapy
📍

Where

1 site
Erasmus MC
Rotterdam, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy